These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 21725702)
1. Apelin, diabetes, and obesity. Castan-Laurell I; Dray C; Attané C; Duparc T; Knauf C; Valet P Endocrine; 2011 Aug; 40(1):1-9. PubMed ID: 21725702 [TBL] [Abstract][Full Text] [Related]
2. Expanding role for the apelin/APJ system in physiopathology. Carpéné C; Dray C; Attané C; Valet P; Portillo MP; Churruca I; Milagro FI; Castan-Laurell I J Physiol Biochem; 2007 Dec; 63(4):359-73. PubMed ID: 18457011 [TBL] [Abstract][Full Text] [Related]
3. Apelin/APJ system as a therapeutic target in diabetes and its complications. Hu H; He L; Li L; Chen L Mol Genet Metab; 2016 Sep; 119(1-2):20-7. PubMed ID: 27650065 [TBL] [Abstract][Full Text] [Related]
4. Apelin receptors: From signaling to antidiabetic strategy. Chaves-Almagro C; Castan-Laurell I; Dray C; Knauf C; Valet P; Masri B Eur J Pharmacol; 2015 Sep; 763(Pt B):149-59. PubMed ID: 26007641 [TBL] [Abstract][Full Text] [Related]
5. The apelin receptor APJ: journey from an orphan to a multifaceted regulator of homeostasis. O'Carroll AM; Lolait SJ; Harris LE; Pope GR J Endocrinol; 2013 Oct; 219(1):R13-35. PubMed ID: 23943882 [TBL] [Abstract][Full Text] [Related]
6. Hypothalamic actions of apelin on energy metabolism: new insight on glucose homeostasis and metabolic disorders. Knauf C; Drougard A; Fournel A; Duparc T; Valet P Horm Metab Res; 2013 Dec; 45(13):928-34. PubMed ID: 23950038 [TBL] [Abstract][Full Text] [Related]
7. The Role of Apelin-APJ System in Diabetes and Obesity. Li C; Cheng H; Adhikari BK; Wang S; Yang N; Liu W; Sun J; Wang Y Front Endocrinol (Lausanne); 2022; 13():820002. PubMed ID: 35355561 [TBL] [Abstract][Full Text] [Related]
8. The therapeutic potentials of apelin in obesity-associated diseases. Castan-Laurell I; Dray C; Valet P Mol Cell Endocrinol; 2021 Jun; 529():111278. PubMed ID: 33838166 [TBL] [Abstract][Full Text] [Related]
9. Apelin targets gut contraction to control glucose metabolism via the brain. Fournel A; Drougard A; Duparc T; Marlin A; Brierley SM; Castro J; Le-Gonidec S; Masri B; Colom A; Lucas A; Rousset P; Cenac N; Vergnolle N; Valet P; Cani PD; Knauf C Gut; 2017 Feb; 66(2):258-269. PubMed ID: 26565000 [TBL] [Abstract][Full Text] [Related]
17. Apelin and APJ regulation in adipose tissue and skeletal muscle of type 2 diabetic mice and humans. Dray C; Debard C; Jager J; Disse E; Daviaud D; Martin P; Attané C; Wanecq E; Guigné C; Bost F; Tanti JF; Laville M; Vidal H; Valet P; Castan-Laurell I Am J Physiol Endocrinol Metab; 2010 Jun; 298(6):E1161-9. PubMed ID: 20233941 [TBL] [Abstract][Full Text] [Related]
18. Central apelin controls glucose homeostasis via a nitric oxide-dependent pathway in mice. Duparc T; Colom A; Cani PD; Massaly N; Rastrelli S; Drougard A; Le Gonidec S; Moulédous L; Frances B; Leclercq I; Llorens-Cortes C; Pospisilik JA; Delzenne NM; Valet P; Castan-Laurell I; Knauf C Antioxid Redox Signal; 2011 Sep; 15(6):1477-96. PubMed ID: 21395477 [TBL] [Abstract][Full Text] [Related]
19. [The APJ receptor: a new therapeutic approach in diabetic treatment]. Masri B; Dray C; Knauf C; Valet P; Castan-Laurell I Med Sci (Paris); 2015 Mar; 31(3):275-81. PubMed ID: 25855281 [TBL] [Abstract][Full Text] [Related]
20. The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications. Ladeiras-Lopes R; Ferreira-Martins J; Leite-Moreira AF Arq Bras Cardiol; 2008 May; 90(5):343-9. PubMed ID: 18516406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]